Clin2
NCT07872436Possibly a fitNot yet recruiting

VCT220 tablets for type 2 diabetes with poor blood sugar control

Type 2 Diabetes Mellitus (DM)

Part of Hormones & metabolism clinical trials.

This trial tests an oral medication called VCT220, which may help lower blood sugar in adults with type 2 diabetes who aren't well controlled with current treatments. It aims to see if it's safe and effective compared to standard care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old
  • You've had type 2 diabetes for at least 3 months and manage it with diet and exercise alone, or you take metformin (with or without an SGLT2 inhibitor) for at least 8 weeks
  • Your average blood sugar (HbA1c) is between 7.5% and 10.5% at screening
  • You weigh at least 50 kg and your BMI is between 19 and 35
  • Your weight hasn't changed more than 5% in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07599410Recruiting· Phase 2
Testing HRS9531 for Type 2 Diabetes Blood Sugar Control

This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.

Beijing, Beijing Municipality
NCT07755150Not yet recruiting· Phase 2
Study of an experimental pill for type 2 diabetes

This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.

Beijing
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07156500Not yet recruiting· Phase 3
Investigational drug study for type 2 diabetes not controlled by diet and exercise

This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.

Beijing, Beijing Municipality
NCT07082114Recruiting· Phase 3
Testing a new tablet for type 2 diabetes

This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.

Yueyang, Hunan

Hear when a new Type 2 Diabetes Mellitus (DM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.